BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopez T, Ramirez A, Benitez C, Mustafa Z, Pham H, Sanchez R, Ge X. Selectivity Conversion of Protease Inhibitory Antibodies. Antib Ther 2018;1:55-63. [PMID: 30406213 DOI: 10.1093/abt/tby008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Tran VL, Lux F, Tournier N, Jego B, Maître X, Anisorac M, Comtat C, Jan S, Selmeczi K, Evans MJ, Tillement O, Kuhnast B, Truillet C. Quantitative Tissue Pharmacokinetics and EPR Effect of AGuIX Nanoparticles: A Multimodal Imaging Study in an Orthotopic Glioblastoma Rat Model and Healthy Macaque. Adv Healthc Mater 2021;10:e2100656. [PMID: 34212539 DOI: 10.1002/adhm.202100656] [Reference Citation Analysis]
2 Ingham A, Wharton L, El Sayed T, Southcott L, McNeil BL, Ezhova MB, Patrick BO, Jaraquemada-Peláez MG, Orvig C. H2ampa─Versatile Chelator for [203Pb]Pb2+, [213Bi]Bi3+, and [225Ac]Ac3. Inorg Chem 2022;61:9119-37. [PMID: 35678752 DOI: 10.1021/acs.inorgchem.2c00636] [Reference Citation Analysis]
3 Zhang D, Jin Q, Jiang C, Gao M, Ni Y, Zhang J. Imaging Cell Death: Focus on Early Evaluation of Tumor Response to Therapy. Bioconjug Chem 2020;31:1025-51. [PMID: 32150392 DOI: 10.1021/acs.bioconjchem.0c00119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
4 Janoniene A, Petrikaite V. In Search of Advanced Tumor Diagnostics and Treatment: Achievements and Perspectives of Carbonic Anhydrase IX Targeted Delivery. Mol Pharm 2020;17:1800-15. [PMID: 32374612 DOI: 10.1021/acs.molpharmaceut.0c00180] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]